可切除原发性十二指肠恶性肿瘤X线征象分析

目的 :对可切除的原发性十二指肠恶性肿瘤X线征象进行分析。方法 :对 2 6例原发性十二指肠恶性肿瘤胃肠道造影及CT征象进行了回顾性对比分析总结。结果 :全部病例均经手术病理证实 ,其中腺癌 2 2例 ,平滑肌肉瘤 3例 ,非何杰金氏淋巴瘤 1例。描述包括肿瘤的部位 ,造影X线表现 (黏膜破坏 ,充盈缺损及龛影 ,管腔不规则狭窄 ,肠腔外改变等 )及CT表现 (肠壁增厚肠腔狭窄 ,局部肿块 ,梗阻性改变及转移 )。不能手术切除的影像学征象为 :肿瘤直径大于 6cm ;腹腔、系膜淋巴结成团肿大 ;腔静脉、肠系膜动静脉等重要血管管径被包绕大于 2 / 3时。结论 :CT与X线造影对肿瘤的位置、大小、形态 ,肿瘤的继发征象的术前评价 ,能够提供能否手术切除的重要依据。     

高等医学院校医学化学教材改革的几点思考

医学的发展已进入分子水平，医学生必须具有扎实的化学基础才能适应专业学习及临床、科研工作的需要。现行医学化学教材大多沿用几十年前的模式，部分内容陈旧滞后，实用性不强。面对现实，改革势在必行。我们认为，突出重点、注重实用、体现医学特色应作为改革的方向。     

Targeting of "T" lymphocytes against human hepatoma cells by a bispecific monoclonal antibody: role of different lymphocyte subsets.

In an attempt to construct bispecific monoclonal antibodies (bimAbs) able to target cytotoxic T lymphocytes against human hepatoma cells, an HGPRT-deficient mutant of the Hepama-6 hybridoma, which produces an antihuman-hepatoma mAb, was directly fused with splenocytes from Balb/C mice immunized by a polyclonal cytotoxic T-cell line. Hybrid hybridomas were selected in HAT medium, and their supernatants were directly screened for the ability to induce IL-2-cultured cytotoxic T lymphocytes to kill hepatoma cells in a 51Cr-release assay. The selected hybrid hybridoma, termed DQ-33, secretes a bimAb, which reacts with a CD3-associated determinant. When resting peripheral-blood lymphocytes were used as effector cells, virtually no cytolytic activity could be induced by DQ-33, whereas phytohemagglutinin-activated lymphocytes that had been expanded in vitro in IL-2-containing medium could be efficiently targeted against hepatoma cells. Targeting by DQ-33 bimAb was analyzed on different subsets of IL-2-cultured lymphocytes. It was evident that CD+4-8+ TCR alpha/beta+ and CD3+4-8-TCR gamma/delta+ lymphocytes were efficiently induced by bimAb to lyse human hepatoma cells, whereas no induction of cytolysis could be observed when CD3 + 4 + 8-TCR alpha/beta+ cells were used as effectors. DQ-33 bimAb was also able to induce lymphokine secretion (IL-2, GM-CSF and TNF-alpha) by all the different subsets of lymphocytes analyzed in the presence of target cells expressing the relevant antigen, independent of the expression of cytolytic activity.     

维胺酯-β-环糊精包合物的研究

应用３因素８水平的均匀设计方法，优化出维胺酯－β－环糊精包合物最佳制备条件，所得包合物的包合率为９９．３％，其表观稳定常数为１３９４Ｍ－１．     

Point mutation in the parkin gene on patients with Parkinson’s disease

Summary To investigate the distribution of possible novel mutations from parkin gene in variant subset of patients with Parkinson’s disease (PD) in China and explore whether parkin gene plays an important role in the pathogenesis of PD, 70 patients were divided into early-onset group and late-onset group; 70 healthy subjects were included as controls. Genomic DNA from 70 normal controls and from those of PD patients were extracted from peripheral blood leukocytes by using standard procedures. Mutations of parkin gene (exon 1–12) in all the subjects were screened by PCR-single strand conformation polymorphism (SSCP), and further sequencing was performed in the samples with abnormal SSCP results, in order to confirm the mutation and its location. A new missense mutation Gly284Arg in a patient and 3 abnormal bands in SSCP electrophoresis from samples of another 3 patients were found. All the DNA variants were sourced from the samples of the patients with early-onset PD. It was concluded that Parkin point mutation also partially contributes to the development of early-onset Parkinson’s disease in Chinese. WANG Tao, male, born in 1961, Associate Professor This work was supported by grants from the key program of the special scientific project of Scientific & Technologic Agency of Hubei Province (Serial No. 2001AA308B01) and the Hygienic Research Project of Hygienic Agency of Hubei province (Serial No. WJ 01529).     

超声热疗临床应用的研究

目的：通过超声热疗配合常规放疗治疗晚期恶性肿瘤的临床研究，评价超声热疗的疗效及与疗效有关的加热参数。材料和方法： 对１７ 例晚期恶性肿瘤的１７ 个病灶用常规放疗加超声热疗。放疗用直线加速器外照射，每次２ Ｇｙ、周５ 次， 总剂量４０～７０ Ｇｙ。热疗在放疗后３０ ｍ ｉｎ 内进行，每周加热１～２ 次，每次加温时间 ６０ ｍ ｉｎ，６～８ 次一疗程。全例病人每次加温时实测肿瘤内温度。结果：在可评价的１３例中，ＣＲ ２３．１％ （３／１３）、ＰＲ ４６．２％ （６／１３）、ＮＣ ２３．１％ （３／１３）、ＰＤ ７．７％ （ １／１３） ， 有效率（ＣＲ＋ ＰＲ）为６９．３％ 。肿瘤中心部温度达到４２．５℃以上的累积时间和总加热次数是决定疗效的重要参数。在１７ 例患者的 ８９ 次加温中，副作用的发生率相对较低。结论：使用超声热疗配合放疗，只要实现满负荷加温，进一步提高肿瘤的局部控制率是完全可能的     

Glomus tumours of the hand and foot

Summary. Between 1982 and 1991 we treated 48 patients with a glomus tumour in the hand or foot. There were 42 women and 6 men, aged between 14 and 61 years. Forty-five tumours were in the subungual region and 41 were on the anterolateral aspect of a distal phalanx. The lesions presented with a classic triad of pain, tenderness and sensitivity to temperature, particularly cold. Excision of the tumour was curative.

---

Resumé. Entre 1982 et 1991, 48 patients présentant une tumeur glomique de la main et du pied ont été traités dans notre département. Il y avait 42 femmes et 6 hommes, agés de 14 à 61 ans (moyenne 38 ans). 45 tumeurs étaient en situation sous-inguéale et 41 en situation latéro-palmaire de la phalange distale. 44 se situaient au niveau de la main et 4 au niveau du gros orteil. Ces lésions sont souvent non palpables fréquemment invisibles et habituellement indétectables à la radiographie. Cependant, le diagnostic est assez facile, lorsqu’existe la triade symptomatique: douleur, tumefaction molle et sensibilité au froid. L’excision complète après dissection soigneuse est le traitement adéquate. Le suivi des 48 malades a toujours montré une guérison complète.

---

---

Accepted: 21 May 1996